Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-09-17

Clinical Trial Update: Neubotulinum Toxin Injection in Cerivical Dystonia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial of Neubotulinum toxin injection for cervical dystonia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Neubotulinum toxin injection

Snippet

Sponsor: Department of Medical Services Ministry of Public Health of Thailand | Conditions: Cervical Dystonia | Phase 3 | Status: COMPLETED